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Decreased activity in the reward 
network of chronic insomnia 
patients
Yuki Motomura1,2,3*, Ruri Katsunuma1, Naoko Ayabe1,4, Kentaro Oba1,5, Yuri Terasawa1,6, 
Shingo Kitamura1, Yoshiya Moriguchi1,3, Akiko Hida1, Yuichi Kamei1,7 & Kazuo Mishima1,8,9*
In modern society, many people have insomnia. Chronic insomnia has been noted as a risk factor for 
depression. However, there are few functional imaging studies of the brain on affective functions 
in chronic insomnia. This study aimed to investigate brain activities induced by emotional stimuli in 
chronic insomnia patients. Fifteen patients with primary insomnia and 30 age and gender matched 
healthy controls participated in this study. Both groups were presented images of fearful, happy, and 
neutral expressions consciously and non-consciously while undergoing MRI to compare the activity in 
regions of the brain responsible for emotions. Conscious presentation of the Happy-Neutral contrast 
showed significantly lower activation in the right orbitofrontal cortex of patients compared to healthy 
controls. The Happy-Neutral contrast presented in a non-conscious manner resulted in significantly 
lower activation of the ventral striatum, right insula, putamen, orbitofrontal cortex and ventral 
tegmental area in patients compared to healthy controls. Our findings revealed that responsiveness 
to positive emotional stimuli were decreased in insomniac patients. Specifically, brain networks 
associated with rewards and processing positive emotions showed decreased responsiveness to happy 
emotions especially for non-conscious image. The magnitude of activity in these areas also correlated 
with severity of insomnia, even after controlling for depression scale scores. These findings suggest 
that insomnia induces an affective functional disorder through an underlying mechanism of decreased 
sensitivity in the regions of the brain responsible for emotions and rewards to positive emotional 
stimuli.
Several recent large-scale studies have shown that approximately one-fourth of adults complain of sleep prob-
lems, and that 10–15% of them trouble functioning during the day because of insomnia. Additionally, around 
6–10% of the general population meet the clinical diagnostic criteria of chronic  insomnia1. Insomnia has a high 
prevalence, and it can cause various physical and psychological symptoms such as depression, psychomotor 
impairment, and easy fatigability. Thus, it is a common disease that should not be overlooked in public health 
studies. Insomnia has been found to accompany many other psychiatric conditions, including depression, and 
patients with depression have experienced a decrease in symptoms after receiving treatment for  insomnia2,3. 
Strong mutual relationships between sleep problems and mood modulation are thus expected.
Furthermore, chronic insomnia has been identified as a risk factor for depression. Ford et al. surveyed 7954 
people in the general population and found that those with insomnia, both at baseline and at the one-year follow-
up (persistent insomniacs), had a 40-fold higher risk of developing depression than healthy  sleepers4. A more 
recent cohort  study5 also showed a two-fold increase in the risk of depression 3.5 years after being diagnosed 
with insomnia. Furthermore, a meta-analysis reported that the odds of depression increased by 2.1 in people 
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with  insomnia6, which confirms that chronic insomnia is a risk factor for depression. Additionally, insomnia 
has been found to be a risk factor for anxiety  disorders7.
The “hyperarousal” theory states that insomnia patients are in states of excessive alertness, both physio-
logically and  psychologically8–10; this is considered as an explanation for the psychological and physiological 
symptoms in insomnia. An increased heart rate, increased sympathetic nerve activity in heart rate variabil-
ity, decreased parasympathetic nerve  activity11–13, higher levels of  cortisol14–18, decreased melatonin  levels19,20, 
increased noradrenaline  levels21, increased brain glucose  metabolism22,23, hyperarousal of the cortex (observed as 
rapid waves on electroencephalography)24–29, and many other findings supporting physiological and psychologi-
cal hyperactivity are observed in individuals with difficulty sleeping, including insomnia patients. Hyperarousal 
has also been associated with the symptoms of depression in a cohort  study30.
Multiple studies have investigated the personality traits associated with insomnia and mood modulation. 
Kales et al.31 conducted a survey using the Minnesota Multiphasic Personality Inventory in insomnia patients 
and found that they had high scores in the depression, psychasthenia, and conversion hysteria subscales, suggest-
ing the presence of mood modulation problems in insomnia patients. Based on these results, an internalization 
model for handling conflicts in insomnia patients has been proposed, which is associated with the physiological 
hyperarousal and individual characteristics of insomnia, wherein internal conflicts induce high levels of emo-
tional  arousal32. In a study by Koffel and  Watson33, 349 healthy young adults, 213 older adults, and 213 insomnia 
patients were surveyed to study the associations between the problems related to insomnia during the night 
(prolonged sleep latency, difficulty maintaining sleep) and during the day (fatigue, drowsiness), depression, and 
anxiety. They found that both day- and night-time problems were associated with anxiety, depression, post-
traumatic stress disorder, and social phobia. However, anxiety and depression were more strongly associated 
with the day-time problems of insomnia. Furthermore, day-time problems were associated with a high negative 
emotional reactivity and low positive emotional reactivity in a survey using the Positive and Negative Affect 
Schedule. This suggests that day-time sleep-related symptoms are associated with a greater risk for depression, 
which can be caused by insomnia, than night-time symptoms.
In addition to the night-time symptoms, it is necessary to investigate the mechanisms underlying the 
decreased affective function during day-time arousal in chronic insomnia patients. Recent neuroimaging studies 
have revealed that these patients have altered functional coupling networks in the amygdala at rest when com-
pared with that in healthy  individuals34,35. Baglioni et al. reported increased amygdala activity levels in response 
to sleep-related stimuli in patients with  insomnia36. Although they found that in healthy individuals, the levels 
of activity were proportional to the magnitude of arousal generated in response to common affective stimuli, 
there were no changes in the magnitude of the negative valence. A study by Klumpp et al.37 is an example of a 
similar attempt that has been made previously; they reported that worse sleep quality (i.e., a higher Pittsburgh 
sleep quality index [PSQI] total scores) predicted increased left amygdala-subgenual anterior cingulate func-
tional connectivity and reduced its connectivity with the posterior cerebellar lobe and superior temporal gyrus. 
However, neurofunctional imaging studies related to affective function in chronic insomnia are rare, and the 
detailed mechanisms underlying the changes in activity due to insomnia are unknown. In this study, we used 
facial expression tasks with the aim of investigating the brain areas associated with affective states provoked by 
representations of facial expressions in patients with severe chronic insomnia.
Methods
Ethical considerations. This study was approved by the ethics committee of the National Center of Neu-
rology and Psychiatry, and conforms to the principles of the Declaration of Helsinki. All participants provided 
written informed consent.
Participants. The participants included 15 patients who visited the National Center of Neurology and Psy-
chiatry Hospital Sleep Disorders Center and were diagnosed with primary insomnia as defined in the Diagnostic 
and Statistical Manual of Mental Disorders and 30 age- and sex-matched healthy individuals who were recruited 
for this study. The experiment was conducted between January 2011 and December 2014.
Experimental protocol. Insomnia patient group. Fifteen patients were assigned to the insomnia patient 
(PT) group. Magnetic resonance imaging (MRI) was conducted after a 3-day washout period for hypnotics, 
managed by the attending physician. Participants filled out the  PSQI38 and Athens Insomnia Scale (AIS)39 after 
arriving at the center to evaluate the severity of their sleep disorder or insomnia and the Zung Self-Rating De-
pression Scale (SDS)40 to evaluate the severity of their depression. Participants aged ≥ 60 years also underwent 
the Mini-Mental State Examination (MMSE)41 before they performed the emotional-face viewing task. The ex-
periments were conducted between 10:00 and 15:00.
Insomnia patients were excluded if they met the following criteria: patients with serious physical condition, 
psychiatric diseases, sleep disorders other than primary insomnia, implanted metal devices such as pacemak-
ers, ophthalmic conditions including abnormal color perception, patients doing shift work, patients who had 
traveled abroad to a region with a 6-h or greater time difference in the past 3 months, patients with 200 mg/day 
or more caffeine intake, heavy smokers (those who would find it stressful to abstain from smoking for 5 days), 
and patients suspected to have cognitive decline (MMSE score ≤ 25 points).
Healthy control group. The healthy control (HC) group comprised thirty healthy individuals, age- and sex-
matched to the insomnia patients. They visited the study site a week before the experiment for briefings on the 
nature and purpose of the experiment, to provide their written consent, and to complete online questionnaires 
to confirm the absence of pre-existing sleep disorders. They filled out the following questionnaires to screen 
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for certain suspected diseases: the  PSQI38 and  AIS39 for insomnia, Epworth Sleepiness  Scale42 for hypersom-
nia, STOP-Bang  questionnaire43 for sleep apnea, the International Restless Legs Syndrome Study Group rating 
scale for the severity of restless legs  syndrome44 and parasomnia, the Munich Parasomnia  Screening45 for sleep 
behavior disorder, and the Rapid Eye Movement Sleep Behavior Disorder Screening  Questionnaire46 for rapid 
eye movement sleep behavior disorder.
A sleep–wake cycle survey by actigraphy and sleep apnea screening and pulse measurement using pulse 
oximetry were conducted for the first night at home for one week. Participants revisited the laboratory one week 
after the tests at home to fill the same questionnaires as the PT group, undergo the MMSE, and perform the 
emotional-face viewing task. The tests were conducted between 10:00 and 15:00.
The exclusion criteria for the healthy participants were as follows: those with any of the following sleep 
disorders—insomnia, hypersomnia, sleep apnea, parasomnia, rapid eye movement sleep behavior disorder, or 
circadian rhythm sleep disorder; any serious physical conditions, use of medication or other substances that 
may affect the results of the study (hypnotics, drugs that induce sleepiness such as anti-histamines and steroids); 
psychiatric diseases; implanted metal devices such as pacemakers; ophthalmic conditions including abnormal 
color perception; individuals doing shift work; individuals who had traveled abroad to a region with a 6-h or 
greater time difference in the past 3 months; individuals with 200 mg/day or more caffeine intake, heavy smok-
ers (those who would find it stressful to abstain from smoking for 5 days); and patients with suspected cognitive 
decline (an MMSE score of ≤ 25).
Emotional-face viewing task. The emotional-face viewing task developed by one of the authors of this 
 study47 was conducted while the participants underwent MRI as shown in Fig. 1. The participants were pre-
sented images of emotional facial expressions under the following conditions: (1) a conscious condition wherein 
the emotional facial expression image was presented for long enough for the participant to visually recognize 
it consciously or (2) a non-conscious condition, wherein the emotional facial expression image was presented 
for too short a duration for the participant to consciously recognize it, following which it was masked with a 
neutral expression. The 48 images used as stimuli in this study were selected from two standardized facial stimuli 
sets (Ekman and  Friesen48 and Advanced Telecommunications Research Institute  International49: http://www.
Figure 1.  Emotional-face viewing task. Facial pictures depicting fearful, happy, or neutral expressions were 
used as the stimuli and were presented either non-consciously or consciously. In a non-conscious trial, an 
emotional image (either fearful, happy, or neutral) was implicitly presented for 26 ms, followed by an explicit 
presentation of a neutral “masking” face of the same individual as the preceding implicit emotional face (when 
the implicit face was neutral, the following explicit mask was of a different person of the same sex) for 174 ms. 
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atr-p.com/produ cts/face-db.html), and included fearful, happy, and neutral faces from four Japanese and four 
Western individuals of both genders. For both the conscious and non-conscious conditions, a point image was 
presented for 1000 ms to guide the participants’ gaze. Following this, for the conscious condition, one of the 
facial expressions (fearful, happy, or neutral) was presented for 200 ms. For the non-conscious condition, one 
of the facial expressions was presented for 26 ms, after which the image was backward-masked by a neutral face 
from the same individual. When a neutral image was presented first, an image of the neutral expression from 
a different individual of the same sex was presented for backward masking. Images were presented in blocks of 
eight trials. The target stimulus was presented randomly during each block, and participants were asked to press 
a button to react. During the rest block, the gazing point image was presented for 15 s. Each of the two sessions 
consisted of the following sequence repeated six times with different kinds of facial expressions: non-conscious 
condition block → conscious condition block → rest block. The second session was conducted after a 1–2-min 
break.
After the completion of each session, the participants were asked to report their subjective sleepiness during 
the task on the following scale: 0 = Not sleepy at all, 1 = Slightly sleepy, 2 = Sleepy, 3 = Very sleepy, and 4 = I fell 
asleep for a little bit. The mean scores of the subjective sleepiness for the two sessions were calculated for analysis.
After completing the two sessions, the participants were asked to report how they saw the masked face using 
the following scale: 0 = It was completely unrecognizable, 2 = I saw something, but I was not sure what kind of 
expression it was, 3 = I was able to recognize the expression in some of the pictures, and 4 = I recognized the 
expression in almost all the pictures.
There were no participants who answered 3 or 4 with regards to how they saw the masked face.
Functional MRI data acquisition. A 3  T MRI Verio (Siemens AG. München, Germany) was 
used for the functional MRI (fMRI). Single-shot echo-planar imaging [TR/TE = 2500  ms/25  ms, 30 axial 
slices, voxel size = 6  mm × 6  mm × 4  mm, 1  mm inter-slice gap, flip angle 90°, matrix size = 64 × 64, field of 
view = 384 mm × 384 mm] was used for the functional imaging of the participants while they executed the task. 
During each session, 137 scans were taken, and the first five scans were discarded from analysis.
fMRI data analysis. The SPM8 (Wellcome Department of Imaging Neuroscience; http://www.fil.ion.ucl.
ac.uk/spm/softw are/spm8/) was used for the brain functional imaging data analyses. Functional images were 
motion and slice timing-corrected, co-registered to a magnetization prepared-rapid gradient echo structural 
image, spatially normalized to the Montreal Neurological Institute template, and smoothed with an 8 mm full-
width half maximum Gaussian kernel. The time-series data including the 3D blood-oxygen-level-dependent 
signals of the participants were analyzed with the general linear model (first-level fixed model effect). The time-
series of each session was convolved with the canonical hemodynamic response implemented function in SPM8, 
and the functions of the hypothesized hemodynamics for the various conditions of the stimulus presentation 
were created. The time-series of the blood flow models for the responses to the six emotional and conscious 
stimulus categories (non-conscious/conscious happy, non-conscious/conscious fear, and non-conscious/con-
scious neutral) and the time-series data of the variables related to the six body movements were built into the 
design matrix as a regressor. Actual blood-oxygen-level-dependent signals were analyzed voxel by voxel with a 
general linear model, and the beta values corresponding to each regressor were calculated.
For inter-participant testing, the beta values between the conditions of interest for each voxel were analyzed 
using a paired t-test. The contrast (activity from viewing the neutral expression image subtracted from the activity 
from viewing the emotional expression image) was then created. A total of four contrasts for the fear–neutral 
and happy–neutral expressions presented consciously and non-consciously were generated.
Areas known to have important associations with positive or negative emotions, i.e., the amygdala, insula, 
anterior cingulate cortex, and areas involved in responding to pleasurable stimuli or motivation for  reward50–57, 
were selected as regions of interest. Masks for the right and left amygdala, right and left insula, anterior cingulate 
cortex, corpus striatum (putamen + caudate nucleus), and right and left orbitofrontal areas were created using 
the Anatomical Automatic Labeling from the SPM WFU PickAtlas toolbox (Wake Forest University; http://fmri.
wfubm c.edu/downl oads/WFU_PickA tlas_User_Manua l.pdf). A mask for the ventral tegmental area, for which a 
corresponding item does not exist in the Anatomical Automatic Labeling, was created with a 5-mm radius sphere 
centered on the peak site, as described in a previous  study58. A covariance analysis was performed with sex, age, 
sleepiness, and recognition of non-conscious images as covariates for voxels within the masks to compare the 
various conditions between the HC and PT groups. A small volume correction for the multiple comparisons 
was performed at the peak level within the masks. The risk level for the multiple comparison correction was set 
at a family-wise error of 5% at peak level.
MRI partial correlation analysis: severity of insomnia and depression scale scores. The sites 
with significant differences in the non-conscious happy–neutral contrasts were extracted using MarsBaR, and 
their correlations with the AIS, PSQI, and SDS scores were studied. There were two clusters in the right insula; 
thus, the cluster with higher statistical values was used for analysis. Furthermore, SDS scores were significantly 
higher in the PT group. A partial correlation analysis was performed to show that the high SDS scores in the 
PT group were attributed to insomnia and not to a spurious correlation with high depression scores to assess 
whether the correlations with the PSQI and AIS were still significant after controlling for the severity of depres-
sion as measured using the SDS. Multiple comparison correction was performed by adjusting the false discovery 
rate: FDR (Benjamini and  Hochberg59 method).
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Other statistical analyses. A t-test (two-tailed) was used to analyze the questionnaire scores and behav-
ioral data under various conditions for the HC and PT groups. Correlations between inter-participant variables 
were analyzed by calculating Pearson’s product-moment correlation coefficient. SPSS PASW statistics 18 (Inter-
national Business Machines Corporation, New York, USA) was used for the statistical analyses.
Results
Basic parameters of the participant groups. The data of each participant group are shown in Table 1. 
There were no significant differences in age, sex ratio, subjective sleepiness, recognition of the masked image, or 
button-pressing reaction time between the two groups. The PSQI, AIS, and SDS scores were significantly higher 
in the PT group than in the HC group.
Comparison of the fMRI data. To investigate the functional changes in the brains of the insomnia 
patients, we compared the activity in the regions of their brain responsible for emotions to that in healthy con-
trols. The sites with significant differences and their statistical values are shown in Table 2.
There were no significant differences between the groups in brain activity in response to the conscious pres-
entation of fear in any of the observed regions.
Compared to the healthy controls, insomnia patients had significantly lower activity levels in the middle and 
posterior parts of the left insula in response to the non-conscious presentation of fear (Fig. 2: p < 0.05, small 
volume correction). There were no areas of the brain with more activity in the insomnia patients than in healthy 
controls.
Table 1.  Participant demographic data. All values are expressed as mean (SD). HC Healthy control group, PT 
Insomnia patient group, PSQI The Pittsburgh Sleep Quality Index, AIS Athens Insomnia Scale, SDS Self-Rating 
Depression Scale. Degrees of freedom (df) = 43.
HC PT t p
Age 60.5 (15) 60.3 (16.5) 0.6 ns
Sex ratio (M:F) 21:9 11:4 χ2 = 0.18 ns
PSQI 4 (1.76) 12.73 (2.4) 5.92 < 0.001
AIS 2.2 (1.73) 9.8 (2.98) 4.31 < 0.001
SDS 32.87 (7.33) 39.4 (6.41) 2.82 < 0.01
Sleepiness 0.51 (0.6) 0.93 (1.06) 0.91 ns
Awareness 1.33 (0.47) 1.53 (0.83) 0.87 ns
Number of responses 11.4 (2.07) 11.6 (1.17) 0.4 ns
Reaction time (ms) 390.4 (184.7) 436.3 (144.2) 0.97 ns
Table 2.  Brain regions with statistically significant differences in activation between insomniacs and healthy 
controls (p < 0.05, small volume correction). BA Brodmann area, MNI Montreal Neurological Institute 
template. Cluster k*p < 0.001 threshold. † p < 0.05 threshold (p-value for the ventral tegmental area cluster 
was greater than 0.001, but significant at peak level small volume correction); HC = healthy control group; 
PT = insomnia patient group.
Brain region BA
MNI
t Cluster k*x y z
Non-conscious fear minus neutral, HC minus PT
Left Insula 13 − 38 − 18 14 4.78 40
Left Insula 13 − 36 − 10 − 8 3.64 7
Conscious happy minus neutral, HC minus PT
Right Inferior orbitofrontal 47 42 36 − 6 3.91 15
Non-conscious happy minus neutral, HC minus PT
Left Lentiform nucleus Caudate Head − 4 10 0 5.57 361
Putamen − 16 12 − 4 4.39
Caudate body − 10 − 2 14 4.32
Right Lentiform nucleus Putamen 24 4 − 2 5.24 127
Right Insula 13 38 14 6 4.52 37
Left Inferior orbitofrontal 47 − 46 30 − 6 4.35 110
Right Inferior orbitofrontal 47 42 40 − 6 4.09 39
Right Insula 13 38 22 − 6 3.89 27
Midbrain 2 − 20 − 16 2.99 (35†)
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Figure 2.  Brain activity in response to the non-conscious presentation of fear. The map shows a significantly 
greater activation in response to non-conscious fearful face stimuli in the healthy control than the insomnia 
patient group. Significant differences were observed in the left insula. Significant clusters are rendered on a T1 
anatomical referential image displayed in neurological convention, with the left side corresponding to the left 
hemisphere.
Figure 3.  Brain activity in response to the conscious presentation of happiness. The map shows a significantly 
greater activation in response to conscious happy face stimuli in the healthy control than the insomnia patient 
group. Significant differences were observed in the right orbitofrontal cortex (OFC). Significant clusters 
are rendered on a T1 anatomical referential image displayed in neurological convention, with the left side 
corresponding to the left hemisphere.
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The activity in response to the conscious presentation of happiness was significantly decreased in the right 
orbitofrontal cortex of insomnia patients compared to that of healthy controls (Fig. 3; p < 0.05, small volume 
correction). There were no significant differences in the brain activity in response to the facial expressions pre-
sented under other conditions. There were no sites showing a greater activity in the insomnia patients than in 
healthy controls.
In response to the non-conscious presentation of happiness, the activity in the ventral striatum, putamen, 
ventral tegmental area, bilateral orbitofrontal cortices, and the right anterior insula was significantly lower in 
insomnia patients than in healthy controls (Fig. 4: p < 0.05, small volume correction). There were no significant 
differences in the brain activity in these regions in response to the presentation of facial expressions in other 
conditions. There were no sites with greater activity in the insomnia patients than in healthy controls.
Correlation analysis. The activity in the areas associated with reward had a significant negative correla-
tion with the PSQI and AIS scores. The ventral tegmental area also showed similar correlations, though the 
correlation was not significant. SDS scores had a significant negative correlation with the activity in the right 
orbitofrontal cortex and ventral striatum, but not with that in the right insula (Table 3). All significant results 
survived after FDR correction.
Figure 4.  Brain activity in response to the non-conscious presentation of happiness. The map shows a 
significantly greater activation in response to non-conscious happy face stimuli in the healthy control than the 
insomnia patient group. Significant differences were observed in the ventral striatum, putamen, orbitofrontal 
cortex (OFC), right insula, and ventral tegmental area (VTA). Significant clusters are rendered on a T1 
anatomical referential image displayed in neurological convention, with the left side corresponding to the left 
hemisphere. The cluster shown on the VTA were made using a threshold with a lenient alpha level (p < 0.05, 
k > 5) for visualization purposes.
Table 3.  Correlation matrix analyses between the brain activity and scales of insomnia and depression. L 
left side, R right side, OFC orbitofrontal cortex, VTA ventral tegmental area, vSTR ventral striatum, PSQI 
The Pittsburgh Sleep Quality Index, AIS Athens Insomnia Scale, SDS Self-Rating Depression Scale. † p < 0.1, 
*p < 0.05, **p < 0.01. Degrees of freedom (df) = 45.
R insula L OFC R OFC Putamen VTA vSTR
PSQI − 0.438** − 0.415** − 0.492** − 0.511** − 0.432** − 0.543**
AIS − 0.485** − 0.443** − 0.503** − 0.501** − 0.284† − 0.519**
SDS − 0.273† − 0.198 − 0.329* − 0.225 0.021 − 0.313*
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A partial correlation analysis with SDS scores as a control variable showed that the correlations between the 
brain activity and severity of insomnia were significant for all areas of the brain studied (Table 4). All significant 
results survived after FDR correction.
Discussion
The present study revealed that the activity in the brain’s reward system (corpus striatum, ventral tegmental area, 
orbitofrontal cortex, ventral tegmental area, and right insula) in response to facial expressions of happiness were 
decreased in insomnia patients relative to that in controls. This is the first study to demonstrate that the changes in 
cerebral functions in response to positive emotions are altered in insomnia patients. Furthermore, we found that 
these patterns were observed after controlling for the symptoms of depression and that the severity of insomnia 
had a strong negative correlation with the activity in these brain regions.
The corpus striatum comprises of the putamen, caudate nucleus, nucleus accumbens, and other structures, 
and is well known to be associated with motivation and mood  modulation60,61. The activity in the corpus striatum 
has been strongly associated with stimuli involving positive valence or reward, and this activity correlates strongly 
with the subjective assessment of  valence51–53. The corpus striatum and other areas, such as the orbitofrontal area 
and insula, are also involved in goal-directed behaviors motivated by food or monetary  rewards54–57. A meta-
analysis of reward-related  tasks62 has shown that the corpus striatum is associated with both the prediction and 
consumption of the reward. The corpus striatum receives dopaminergic projections from the ventral tegmental 
area of the midbrain and forms the neural networks responsible for the motivation, reinforcement, and reward 
processes with the surrounding areas, such as the insula, anterior cingulate cortex, and  amygdala63. Activity in 
this dopaminergic system has been documented to play an important role in modulating the brain activity in 
response to positive  rewards60,61.
The activation of the amygdala has been reported in several studies of non-conscious happy facial expression 
presentation  tasks64,65. Many previous studies have reported that the presentation of non-conscious emotional 
facial expressions can elicit behavioral and physiological  responses66, such as judgement  modulation67, a modi-
fication of consumption  behavior68, and non-consciously synchronized facial  expressions69. The difference in the 
activity level between the amygdala and anterior cingulate cortex in response to the non-conscious presentation 
of happy faces versus sad faces has been reported to decrease with antidepressant  therapy70. Though only a small 
number of studies have investigated the responses in the corpus striatum and insula, Chen et al. showed that the 
ventral striatal activity in response to the non-conscious (masked) presentation of an image of a close friend’s 
face smiling predicted subsequent developments in the friendship, and that it seemed to reflect the activity in 
the reward  system71. The present study is the first to reveal that activity in the amygdala and ventral striatum in 
response to positive expression (happy) stimuli presented non-consciously is decreased in insomnia patients.
Only a few fMRI studies have investigated the reward processes in insomnia patients. One study assessed the 
brain activity in adolescent girls as they performed a monetarily rewarding task and detected no changes in the 
activity in the reward system in the brain, but found that the activity in the dorsomedial prefrontal cortex could 
be a mediator of the relationship between insomnia and depressed  mood72. Wang et al. reported an altered corpus 
striatum resting-stage functional connectivity between the default mode network and the sensorimotor network 
in primary insomnia  patients73. Patients with a history of bipolar disorder have decreased activity in the ventral 
striatum and orbitofrontal cortex in response to the conscious presentation of happy expressions compared 
to healthy  individuals74. Decreased amygdala activity has been observed in patients with severe depression in 
response to a happy expression stimulus, but this returned to normal levels during  remission75. Furthermore, 
activity in the amygdala and nucleus accumbens in response to happy expressions is lower in children and 
young adults at a high risk of  depression76. Anhedonia in patients with depression correlates negatively with the 
amygdala and ventral striatum activity associated with the presentation of happy  expressions77. These examples 
show that the activity of the neural networks related to emotions and rewards is decreased in individuals with, 
or at risk of, depression. The similarities between the reactions of the insomnia patients in these studies and 
those in the present study may be related to the lack of motivation and high depressive mood during the day in 
insomnia patients, and their higher risk of developing depression. Moreover, for the non-conscious presentation 
of happiness, the severity of insomnia predicted the activity of these regions, even after controlling for depres-
sion scores. This finding shows that the difference between insomnia patients and healthy individuals observed 
was not a spurious correlation attributed to the highly depressive state of insomnia patients, but supports the 
hypothesis that insomnia is directly linked to abnormal affective functions. Patients with chronic insomnia have 
been shown to exhibit an excessive craving for sleep and abnormal attention to sleep-related  stimuli78,79. Dai 
et al.80 reported that the hyperactivity of the value-based attentional networks was associated with an excessive 
attention to sleep-related stimuli. Furthermore, an association between sleep craving and impaired function 
of the exploratory system, including the reward system, has been reported, and the association between these 
Table 4.  Partial correlation matrix analysis after controlling for depression scale scores. L left side, R right 
side, OFC orbitofrontal cortex, VTA ventral tegmental area, vSTR ventral striatum, PSQI The Pittsburgh Sleep 
Quality Index, AIS Athens Insomnia Scale. *p < 0.05, **p < 0.01. Degrees of freedom (df) = 42.
R insula L OFC R OFC Putamen VTA vSTR
PSQI − 0.379* − 0.376* − 0.426** − 0.473** − 0.469** − 0.487**
AIS − 0.425** − 0.404** − 0.428** − 0.459** − 0.321* − 0.452**
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modulations of brain function and hyperarousal in chronic insomnia patients has been discussed. Moreover, the 
association between the exploratory system and the value-based attentional networks was shown to be reduced 
in insomnia patients than in healthy controls. Our findings of reduced activity in the reward system are also 
consistent with these findings; this effect may be related to the pathogenesis of hyperarousal in insomnia, medi-
ated by the impairment of the proper allocation of reward-based attention in these patients, causing them to pay 
excess attention to sleep-related stimuli.
We expected to find overactivity of the emotion-related areas in insomnia patients due to hyperarousal; 
however, contrary to our expectations, there was no increased activation of the emotion-related areas in the PT 
group compared with the HC group. Conversely, we found reduced activity in the reward network, suggesting 
that the hyperarousal in insomnia is not associated with an overactive state of the entire brain. In this study, the 
middle and posterior parts of the left insula were significantly less activated by the non-conscious presentation 
of fearful faces in insomnia patients than in the control group. A meta-analysis on the functions of the  insula81 
has suggested that there is a strong relationship between affective tasks and the right insula, but associations with 
the middle part of the left insula have not been confirmed. However, significant activity in this region has been 
observed in studies on somatosensory and motor functions. The decreased activity in the middle left insula in 
response to negative stimuli is likely explained by the altered physiological  functioning8–10 associated with the 
hyperarousal in insomnia patients.
A significant difference between the two groups in the brain activity in response to the presentation of fear was 
only observed when the presentation was non-conscious. Conscious presentation of happy expressions generated 
a between-group difference in the orbitofrontal cortex only, while a difference was observed in a broader area 
of the reward system when the presentation was non-conscious. There are two hypothesized reasons for these 
differences in brain activity. First, the non-conscious presentation may have generated simple responses from the 
neighboring systems that were unaltered by the visuo-cognitive or high-order functions of the prefrontal lobe. 
Indeed, a previous study reported that the magnitude of the amygdalar response to non-consciously presented 
emotional expressions was a strong predictor of personality traits and subjective  sleepiness47,82. Etkin et al. inves-
tigated the strength of the correlation between the amygdalar activity and intensity of anxiety when participants 
consciously or non-consciously viewed an expression of fear and found significant correlations between the 
intensity of anxiety and amygdalar activity in response to a non-conscious presentation. They attributed the 
high correlation between the non-conscious processes and anxious traits to the notion that, unlike conscious 
processes, the non-conscious presentation is not affected by an inhibitive response to the presentation of an 
 image82. The second predicted reason is the ceiling effect. While the difference between the two groups in their 
conscious responses to images were negligible, the non-conscious presentation of images may have provided the 
optimal stimulus intensity to observe a difference between the two groups.
This study has several limitations. First, data on the subjective assessments of the facial expression stimuli were 
not collected. Thus, it is unknown whether the stimuli induced pleasant emotions in the participants. Because 
the assessment of emotional stimuli has been reported to lower the activity in the brain regions responsible for 
 emotions83,84, we did not ask participants to make subjective assessments while performing the task. However, 
the activity of the reward system decreased in response to non-conscious presentation; therefore, we assume it 
to be a system that is not directly related to subjective pleasure. This indicates that subjective assessments would 
not be relevant to the results of this study.
The second limitation is related to the sampling method. Although the patients who participated in this study 
encompassed a wide age range, the mean age was approximately 60 years; thus, our findings may not be directly 
comparable to those of previous studies that have used younger participants. A sample with a broader age range 
should be selected for further investigations.
Third, in this study, the PT group had 3-day washout period for hypnotics which was managed by the attend-
ing physician. It is possible that the patients in this group experienced symptoms of rebound insomnia. These 
symptoms might enhance the differences in brain activity between the two groups.
Conclusion
The present study revealed a decreased responsiveness to positive emotional stimuli in regions associated with 
emotions and rewards in insomnia patients. This is the first report to show changes in cerebral functions related 
to positive emotions in insomnia patients, compared with healthy controls. A reduced responsiveness to positive 
stimuli is also observed in patients with depression or bipolar disorder and may be associated with the highly 
increased risk of depression in insomnia patients. Future studies should compare insomniacs to depression 
patients, as well as study whether similar patterns in responsiveness are also observed in people with non-clinical 
insomnia. Insomnia patients often show increased activity of the sympathetic nervous  system11–13 and higher 
levels of physiological markers of stress such as  cortisol14–18, thus the relationships between these markers and 
brain activity should be investigated as well.
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